Literature DB >> 20184521

Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation.

Glenn Lopate1, Robert H Baloh, Muhammad T Al-Lozi, Timothy M Miller, J Americo Fernandes Filho, Oliver Ni, Alison Leston, Julaine Florence, Jeanine Schierbecker, Peggy Allred.   

Abstract

We describe a large family with amyotrophic lateral sclerosis (ALS) caused by an I113T mutation in superoxide dismuatse type 1 (SOD1). The proband developed symptoms typical for ALS at age 39 years and is still walking five years later. Marked phenotypic variability is manifested by her mother with onset of gait difficulty and decision-making problems at age 67 years and a five-year course marked by progressive mild upper motor neuron weakness, frontotemporal dementia and chorea. An aunt's initial symptoms included foot numbness and an uncle with the mutation is asymptomatic. Penetrance is only 50% at age 60 years and 88% at age 80 years with an 86-year-old woman harboring the mutation and having a normal neurologic examination. This family highlights the extreme variability in age of onset, clinical manifestations, disease progression and penetrance due to the I113T SOD1 mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184521     DOI: 10.3109/17482960902898069

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  11 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.

Authors:  Gretchen M Thomsen; Genevieve Gowing; Jessica Latter; Maximus Chen; Jean-Philippe Vit; Kevin Staggenborg; Pablo Avalos; Mor Alkaslasi; Laura Ferraiuolo; Shibi Likhite; Brian K Kaspar; Clive N Svendsen
Journal:  J Neurosci       Date:  2014-11-19       Impact factor: 6.167

3.  Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders.

Authors:  Jonathan Gilley; Oscar Jackson; Menelaos Pipis; Mehrdad A Estiar; Ammar Al-Chalabi; Matt C Danzi; Kristel R van Eijk; Stephen A Goutman; Matthew B Harms; Henry Houlden; Alfredo Iacoangeli; Julia Kaye; Leandro Lima; John Ravits; Guy A Rouleau; Rebecca Schüle; Jishu Xu; Stephan Züchner; Johnathan Cooper-Knock; Ziv Gan-Or; Mary M Reilly; Michael P Coleman
Journal:  Elife       Date:  2021-11-19       Impact factor: 8.713

Review 4.  Familial amyotrophic lateral sclerosis, a historical perspective.

Authors:  T Siddique; S Ajroud-Driss
Journal:  Acta Myol       Date:  2011-10

5.  Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.

Authors:  Holly A Black; Danielle J Leighton; Elaine M Cleary; Elaine Rose; Laura Stephenson; Shuna Colville; David Ross; Jon Warner; Mary Porteous; George H Gorrie; Robert Swingler; David Goldstein; Matthew B Harms; Peter Connick; Suvankar Pal; Timothy J Aitman; Siddharthan Chandran
Journal:  Neurobiol Aging       Date:  2016-12-21       Impact factor: 4.673

6.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

7.  Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study.

Authors:  Emilien Bernard; Antoine Pegat; Juliette Svahn; Françoise Bouhour; Pascal Leblanc; Stéphanie Millecamps; Stéphane Thobois; Claire Guissart; Serge Lumbroso; Kevin Mouzat
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

8.  Genetic overlap between apparently sporadic motor neuron diseases.

Authors:  Marka van Blitterswijk; Lotte Vlam; Michael A van Es; W-Ludo van der Pol; Eric A M Hennekam; Dennis Dooijes; Helenius J Schelhaas; Anneke J van der Kooi; Marianne de Visser; Jan H Veldink; Leonard H van den Berg
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 9.  Genetics of amyotrophic lateral sclerosis: an update.

Authors:  Sheng Chen; Pavani Sayana; Xiaojie Zhang; Weidong Le
Journal:  Mol Neurodegener       Date:  2013-08-13       Impact factor: 14.195

10.  Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.

Authors:  Hung-Jin Huang; Tung-Ti Chang; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.